AAAAAA

   
Results: 1-25 | 26-39
Results: 1-25/39
IRINOTECAN AND CISPLATIN IN UPPER GASTROINTESTINAL MALIGNANCIES
Authors: ENZINGER PC ILSON DH SALTZ LB OREILLY EM KELSEN DP
Citation: Pc. Enzinger et al., IRINOTECAN AND CISPLATIN IN UPPER GASTROINTESTINAL MALIGNANCIES, Oncology, 12(8), 1998, pp. 110-113
PHASE-II TRIAL OF PACLITAXEL, FLUOROURACIL, AND CISPLATIN IN PATIENTSWITH ADVANCED-CARCINOMA OF THE ESOPHAGUS
Authors: ILSON DH AJANI J BHALLA K FORASTIERE A HUANG Y PATEL P MARTIN L DONEGAN J PAZDUR R REED C KELSEN DP
Citation: Dh. Ilson et al., PHASE-II TRIAL OF PACLITAXEL, FLUOROURACIL, AND CISPLATIN IN PATIENTSWITH ADVANCED-CARCINOMA OF THE ESOPHAGUS, Journal of clinical oncology, 16(5), 1998, pp. 1826-1834
ADJUVANT THERAPY FOR COLORECTAL-CANCER (REPRINTED FROM CURR PROBL SURG, VOL 34, PG 601-676, 1997)
Authors: COHEN AM MINSKY BD NELSON H GUNDERSON LL MICHELASSI F SALTZ L KELSEN DP WILLETT CG ARENAS RB FAROUK R SCHILSKY RL
Citation: Am. Cohen et al., ADJUVANT THERAPY FOR COLORECTAL-CANCER (REPRINTED FROM CURR PROBL SURG, VOL 34, PG 601-676, 1997), Current problems in cancer, 22(1), 1998, pp. 5-77
NEOADJUVANT THERAPY OF ESOPHAGEAL CANCER
Authors: KELSEN DP
Citation: Dp. Kelsen, NEOADJUVANT THERAPY OF ESOPHAGEAL CANCER, The cancer journal from Scientific American, 3(3), 1997, pp. 137-139
POTENTIATION OF APOPTOSIS BY FLAVOPIRIDOL IN MITOMYCIN-C-TREATED GASTRIC AND BREAST-CANCER CELLS
Authors: SCHWARTZ GK FARSI K MASLAK P KELSEN DP SPRIGGS D
Citation: Gk. Schwartz et al., POTENTIATION OF APOPTOSIS BY FLAVOPIRIDOL IN MITOMYCIN-C-TREATED GASTRIC AND BREAST-CANCER CELLS, Clinical cancer research, 3(9), 1997, pp. 1467-1472
A PILOT CLINICAL PHARMACOLOGICAL STUDY OF THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL ALONE AND IN COMBINATION WITH DOXORUBICIN/
Authors: SCHWARTZ GK WARD D SALTZ L CASPER ES SPIESS T MULLEN E WOODWORTH J VENUTI R ZERVOS P STORNIOLO AM KELSEN DP
Citation: Gk. Schwartz et al., A PILOT CLINICAL PHARMACOLOGICAL STUDY OF THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL ALONE AND IN COMBINATION WITH DOXORUBICIN/, Clinical cancer research, 3(4), 1997, pp. 537-543
PHASE-I TRIAL OF PN401, AN ORAL PRODRUG OF URIDINE, TO PREVENT TOXICITY FROM FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER
Authors: KELSEN DP MARTIN D ONEIL J SCHWARTZ G SALTZ L SUNG MT VONBORSTEL R BERTINO J
Citation: Dp. Kelsen et al., PHASE-I TRIAL OF PN401, AN ORAL PRODRUG OF URIDINE, TO PREVENT TOXICITY FROM FLUOROURACIL IN PATIENTS WITH ADVANCED CANCER, Journal of clinical oncology, 15(4), 1997, pp. 1511-1517
PREOPERATIVE 5-FU, LOW-DOSE LEUCOVORIN, AND RADIATION-THERAPY FOR LOCALLY ADVANCED AND UNRESECTABLE RECTAL-CANCER
Authors: MINSKY BD COHEN AM ENKER WE SALTZ L GUILLEM JG PATY PB KELSEN DP KEMENY N ILSON D BASS J CONTI J
Citation: Bd. Minsky et al., PREOPERATIVE 5-FU, LOW-DOSE LEUCOVORIN, AND RADIATION-THERAPY FOR LOCALLY ADVANCED AND UNRESECTABLE RECTAL-CANCER, International journal of radiation oncology, biology, physics, 37(2), 1997, pp. 289-295
A PHASE-II STUDY OF TOPOTECAN ADMINISTERED 5 TIMES DAILY IN PATIENTS WITH ADVANCED GASTRIC-CANCER
Authors: SALTZ LB SCHWARTZ GK ILSON DH QUAN V KELSEN DP
Citation: Lb. Saltz et al., A PHASE-II STUDY OF TOPOTECAN ADMINISTERED 5 TIMES DAILY IN PATIENTS WITH ADVANCED GASTRIC-CANCER, American journal of clinical oncology, 20(6), 1997, pp. 621-625
ADJUVANT TREATMENT OF COLORECTAL-CANCER
Authors: SALTZ LB KELSEN DP
Citation: Lb. Saltz et Dp. Kelsen, ADJUVANT TREATMENT OF COLORECTAL-CANCER, Annual review of medicine, 48, 1997, pp. 191-202
PAIN AS A PREDICTOR OF OUTCOME IN PATIENTS WITH OPERABLE PANCREATIC-CARCINOMA
Authors: KELSEN DP PORTENOY R THALER H TAO Y BRENNAN M
Citation: Dp. Kelsen et al., PAIN AS A PREDICTOR OF OUTCOME IN PATIENTS WITH OPERABLE PANCREATIC-CARCINOMA, Surgery, 122(1), 1997, pp. 53-59
PRELIMINARY-RESULTS OF PREOPERATIVE 5-FLUOROURACIL, LOW-DOSE LEUCOVORIN, AND CONCURRENT RADIATION-THERAPY FOR CLINICALLY RESECTABLE T3 RECTAL-CANCER
Authors: GRANN A MINSKY BD COHEN AM SALTZ L GUILLEM JG PATY PB KELSEN DP KEMENY N ILSON D BASSLOEB J
Citation: A. Grann et al., PRELIMINARY-RESULTS OF PREOPERATIVE 5-FLUOROURACIL, LOW-DOSE LEUCOVORIN, AND CONCURRENT RADIATION-THERAPY FOR CLINICALLY RESECTABLE T3 RECTAL-CANCER, Diseases of the colon & rectum, 40(5), 1997, pp. 515-522
ADJUVANT THERAPY FOR COLORECTAL-CANCER - IN BRIEF
Authors: COHEN AM MINSKY BD NELSON H GUNDERSON LL MICHELASSI F SALTZ L KELSEN DP WILLETT CG ARENAS RB FAROUK R SCHILSKY SL
Citation: Am. Cohen et al., ADJUVANT THERAPY FOR COLORECTAL-CANCER - IN BRIEF, Current problems in surgery, 34(8), 1997, pp. 605-676
9-AMINOCAMPTOTHECIN BY 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION IS INACTIVE IN THE TREATMENT OF PATIENTS WITH 5-FLUOROURACIL-REFRACTORY COLORECTAL-CARCINOMA
Authors: SALTZ LB KEMENY NE TONG W HARRISON J BERKERY R KELSEN DP
Citation: Lb. Saltz et al., 9-AMINOCAMPTOTHECIN BY 72-HOUR CONTINUOUS INTRAVENOUS-INFUSION IS INACTIVE IN THE TREATMENT OF PATIENTS WITH 5-FLUOROURACIL-REFRACTORY COLORECTAL-CARCINOMA, Cancer, 80(9), 1997, pp. 1727-1732
A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER
Authors: ROTHENBERG ML MOORE MJ CRIPPS MC ANDERSEN JS PORTENOY RK BURRIS HA GREEN MR TARASSOFF PG BROWN TD CASPER ES STORNIOLO AM VONHOFF DD ALBERTS DS WOLFF R KELSEN DP KOCHA W HALLER DG MODIANOREVAH M MOORE M OKEN MM SCHILSKY RL SHAH A
Citation: Ml. Rothenberg et al., A PHASE-II TRIAL OF GEMCITABINE IN PATIENTS WITH 5-FU-REFRACTORY PANCREAS CANCER, Annals of oncology, 7(4), 1996, pp. 347-353
PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF IRINOTECAN, FLUOROURACIL, ANTI LEUCOVORIN IN PATIENTS WITH ADVANCED SOLID TUMORS
Authors: SALTZ LB KANOWITZ J KEMENY NE SCHAAF L SPRIGGS D STATON BA BERKERY R STEGER C ENG M DIETZ A LOCKER P KELSEN DP
Citation: Lb. Saltz et al., PHASE-I CLINICAL AND PHARMACOKINETIC STUDY OF IRINOTECAN, FLUOROURACIL, ANTI LEUCOVORIN IN PATIENTS WITH ADVANCED SOLID TUMORS, Journal of clinical oncology, 14(11), 1996, pp. 2959-2967
NEOADJUVANT CHEMOTHERAPY PLUS CONCURRENT CHEMOTHERAPY AND HIGH-DOSE RADIATION FOR SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A PRELIMINARY-ANALYSIS OF THE PHASE-II INTERGROUP TRIAL 0122
Authors: MINSKY BD NEUBERG D KELSEN DP PISANSKY TM GINSBERG R BENSON A
Citation: Bd. Minsky et al., NEOADJUVANT CHEMOTHERAPY PLUS CONCURRENT CHEMOTHERAPY AND HIGH-DOSE RADIATION FOR SQUAMOUS-CELL CARCINOMA OF THE ESOPHAGUS - A PRELIMINARY-ANALYSIS OF THE PHASE-II INTERGROUP TRIAL 0122, Journal of clinical oncology, 14(1), 1996, pp. 149-155
PHASE-II STUDY OF ZD-1694 IN PATIENTS WITH ADVANCED GASTRIC-CANCER
Authors: MEROPOL NJ PAZDUR R VINCENT M WILLSON JKV KELSEN DP DOUGLASS HO
Citation: Nj. Meropol et al., PHASE-II STUDY OF ZD-1694 IN PATIENTS WITH ADVANCED GASTRIC-CANCER, American journal of clinical oncology, 19(6), 1996, pp. 628-630
THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS
Authors: FENNELLY D KELSEN DP
Citation: D. Fennelly et Dp. Kelsen, THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF ADENOCARCINOMA OF THE PANCREAS, Hepato-gastroenterology, 43(8), 1996, pp. 356-362
PACLITAXEL IN THE TREATMENT OF PATIENTS WITH UPPER GASTROINTESTINAL CARCINOMAS
Authors: AJANI JA ILSON DH KELSEN DP
Citation: Ja. Ajani et al., PACLITAXEL IN THE TREATMENT OF PATIENTS WITH UPPER GASTROINTESTINAL CARCINOMAS, Seminars in oncology, 23(5), 1996, pp. 55-58
POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS
Authors: SCHWARTZ GK HAIMOVITZFRIEDMAN A DHUPAR SK EHLEITER D MASLAK P LAI L LOGANZO F KELSEN DP FUKS Z ALBINO AP
Citation: Gk. Schwartz et al., POTENTIATION OF APOPTOSIS BY TREATMENT WITH THE PROTEIN-KINASE C-SPECIFIC INHIBITOR SAFINGOL IN MITOMYCIN C-TREATED GASTRIC-CANCER CELLS, Journal of the National Cancer Institute, 87(18), 1995, pp. 1394-1399
EFFICACY OF POSTOPERATIVE 5-FU, HIGH-DOSE LEUCOVORIN, AND SEQUENTIAL RADIATION-THERAPY FOR CLINICALLY RESECTABLE RECTAL-CANCER
Authors: MINSKY BD COHEN AM ENKER WE KELSEN DP KEMENY N FRANKEL J
Citation: Bd. Minsky et al., EFFICACY OF POSTOPERATIVE 5-FU, HIGH-DOSE LEUCOVORIN, AND SEQUENTIAL RADIATION-THERAPY FOR CLINICALLY RESECTABLE RECTAL-CANCER, Cancer investigation, 13(1), 1995, pp. 1-7
PAIN AND DEPRESSION IN PATIENTS WITH NEWLY-DIAGNOSED PANCREAS CANCER
Authors: KELSEN DP PORTENOY RK THALER HT NIEDZWIECKI D PASSIK SD TAO Y BANKS W BRENNAN MF FOLEY KM
Citation: Dp. Kelsen et al., PAIN AND DEPRESSION IN PATIENTS WITH NEWLY-DIAGNOSED PANCREAS CANCER, Journal of clinical oncology, 13(3), 1995, pp. 748-755
CYTOGENETICS OF GASTRIC AND ESOPHAGEAL ADENOCARCINOMAS - 3Q DELETION AS A POSSIBLE PRIMARY CHROMOSOMAL CHANGE
Authors: RAO PH MATHEW S KELSEN DP CHAGANTI RSK
Citation: Ph. Rao et al., CYTOGENETICS OF GASTRIC AND ESOPHAGEAL ADENOCARCINOMAS - 3Q DELETION AS A POSSIBLE PRIMARY CHROMOSOMAL CHANGE, Cancer genetics and cytogenetics, 81(2), 1995, pp. 139-143
ADJUVANT THERAPY OF UPPER GASTROINTESTINAL-TRACT CANCERS
Authors: KELSEN DP
Citation: Dp. Kelsen, ADJUVANT THERAPY OF UPPER GASTROINTESTINAL-TRACT CANCERS, Seminars in oncology, 22(6), 1995, pp. 582-599
Risultati: 1-25 | 26-39